 San Diego, California--Newsfile Corp. - July 28, 2021 - Robbins Geller Rudman Dowd LLP announces the filing of the Athira Pharma class action lawsuit, which charges Athira Pharma, Inc. NASDAQ: ATHA and its CEO and directors, as well as the underwriters of Athira Pharmas September 2020 initial public offering IPO, with violations of the Securities Exchange Act of 1934 andor Securities Act of 1933. The Athira Pharma class action lawsuit seeks to represent:... 